-+ 0.00%
-+ 0.00%
-+ 0.00%

CORRECTION: Cormedix Affirms FY2026 Sales Guidance of $300.000M-$320.000M

Benzinga·03/05/2026 13:25:36
Listen to the news
Cormedix (NASDAQ:CRMD) affirms FY2026 sales outlook from $300.000 million-$320.000 million to $300.000 million-$320.000 million.